Search

Richard R Spaete

age ~77

from Emerald Hills, CA

Also known as:
  • Richard Roger Spaete
  • Richard Emeraldhill Spaete
  • Richard A Spaete
  • Richard Spaete Revocable
  • Dick R Spaete
  • Rick R Spaete
  • Richard R Brown
Phone and address:
720 Lakemead Way, Redwood City, CA 94062
(650)2999567

Richard Spaete Phones & Addresses

  • 720 Lakemead Way, Emerald Hills, CA 94062 • (650)2999567 • (650)2991402
  • Belmont, CA
  • San Mateo, CA
  • Cathedral City, CA
  • Olympic Valley, CA
  • Sunrise Beach, MO
  • Virgie, KY
  • Chicago, IL
  • Wilmington, DE
  • 720 Lakemead Way, Emerald Hills, CA 94062 • (650)7997494

Work

  • Position:
    Financial Professional

Education

  • Degree:
    High school graduate or higher

Emails

Us Patents

  • Non-Splicing Variants Of Gp350/220

    view source
  • US Patent:
    6458364, Oct 1, 2002
  • Filed:
    Apr 24, 2000
  • Appl. No.:
    09/556706
  • Inventors:
    Richard Spaete - Belmont CA
    Winthrop T. Jackman - Berkeley CA
  • Assignee:
    Aviron - Burlingame CA
  • International Classification:
    A61K 39245
  • US Classification:
    4242301, 435 693, 4241861
  • Abstract:
    Compositions comprising gp350 variant DNA and amino acid sequences are provided, as are vectors and host cells containing such sequences. Also provided is a process for producing homogeneous gp350 protein recombinantly and in the absence of production of gp220 protein, pharmaceutical compositions containing such protein and prophylactic treatments making use of such proteins.
  • Human Cytomegalovirus Dna Sequences

    view source
  • US Patent:
    6635477, Oct 21, 2003
  • Filed:
    Jun 26, 2001
  • Appl. No.:
    09/892100
  • Inventors:
    Richard Spaete - Belmont CA
    Tai-An Cha - San Ramon CA
  • Assignee:
    Med Immune Vaccines, Inc. - Mountain View CA
  • International Classification:
    C12N 1574
  • US Classification:
    4353201, 4352351, 4352523, 435 5, 435 691, 536 2372, 4242301
  • Abstract:
    Provided are novel Toledo and Towne human cytomegalovirus DNA sequences (HCMV) and proteins encoded thereby. The sequences are useful in methods and compositions for detecting HCMV infections and in immunogenic compositions for preventing HCMV infections.
  • Non-Splicing Variants Of Gp350/220

    view source
  • US Patent:
    6692749, Feb 17, 2004
  • Filed:
    Nov 28, 2000
  • Appl. No.:
    09/724418
  • Inventors:
    Richard Spaete - Redwood City CA
    Winthrop Jackman - Berkeley CA
  • Assignee:
    MedImmune Vaccines, Inc. - Mountain View CA
  • International Classification:
    A61K 39245
  • US Classification:
    4241861, 4242301, 4352351
  • Abstract:
    Compositions comprising gp350 variant DNA and amino acid sequences are provided, as are vectors and host cells containing such sequences. Also provided is a process for producing homogeneous gp350 protein recombinantly and in the absence of production of gp220 protein, pharmaceutical compositions containing such protein and prophylactic treatments making use of such proteins.
  • Methods And Compositions For Controlling Translation Of Hcv Proteins

    view source
  • US Patent:
    7018984, Mar 28, 2006
  • Filed:
    Jun 6, 1995
  • Appl. No.:
    08/477895
  • Inventors:
    Jang H. Han - Lafayette CA, US
    Richard R. Spaete - Belmont CA, US
    Byoung J. Yoo - Lafayette CA, US
    Byung S. Suh - Lafayette CA, US
    Mark J. Selby - San Francisco CA, US
    Michael Houghton - Danville CA, US
  • Assignee:
    Chiron Corporation - Emeryville CA
  • International Classification:
    A61K 31/7105
    A61K 31/711
    C07H 21/02
    C07H 21/04
    C12N 15/63
  • US Classification:
    514 44, 4353201, 435455, 536 231, 536 241, 536 245
  • Abstract:
    Embodiments of the present invention feature methods and compositions for controlling the translation of viral peptides and proteins from viral nucleic acid, with particular applications to pestivirus and HCV. The methods and compositions feature control elements of the 5′UT region of the viral genome.
  • Attenuation Of Cytomegalovirus Virulence

    view source
  • US Patent:
    7204990, Apr 17, 2007
  • Filed:
    Nov 28, 2000
  • Appl. No.:
    09/724935
  • Inventors:
    George Kemble - Saratoga CA, US
    Gregory M. Duke - Redwood City CA, US
    Richard Spaete - Emerald Hills CA, US
  • Assignee:
    MedImmune Vaccines, Inc. - Mountain View CA
  • International Classification:
    A61K 39/245
    A61K 39/12
    C12Q 1/70
  • US Classification:
    4242301, 4241991, 435 5
  • Abstract:
    A method is provided for attenuating a cytomegalovirus comprising functionally disrupting an open reading frame of a Toledo genome region or its homolog and making chimeric CMV virus genomes.
  • Human Cytomegalovirus Dna Sequences

    view source
  • US Patent:
    7208165, Apr 24, 2007
  • Filed:
    Dec 5, 2005
  • Appl. No.:
    11/293112
  • Inventors:
    Richard Roger Spaete - Emerald Hills CA, US
    Tai-An Cha - San Ramon CA, US
  • Assignee:
    MedImmune Vaccines, Inc. - Mountain View CA
  • International Classification:
    A61K 39/245
  • US Classification:
    4242301, 4242041, 435 6
  • Abstract:
    Provided are novel Toledo and Towne human cytomegalovirus DNA sequences (HCMV) and proteins encoded thereby. The sequences are useful in methods and compositions for detecting HCMV infections and in immunogenic compositions for Preventing HCMV infections.
  • Attenuation Of Cytomegalovirus Virulence

    view source
  • US Patent:
    7537770, May 26, 2009
  • Filed:
    Dec 20, 2006
  • Appl. No.:
    11/613501
  • Inventors:
    George Kemble - Saratoga CA, US
    Gregory M. Duke - Redwood City CA, US
    Richard Spaete - Emerald Hills CA, US
  • Assignee:
    MedImmune, LLC - Gaithersburg MD
  • International Classification:
    A61K 39/12
    A61K 39/245
    C12Q 1/70
  • US Classification:
    4242041, 4242051, 4242301, 435 5
  • Abstract:
    A method is provided for attenuating a cytomegalovirus comprising functionally disrupting an open reading frame of a Toledo genome region or its homolog and making chimeric CMV virus genomes.
  • Attenuation Of Cytomegalovirus Virulence

    view source
  • US Patent:
    7550149, Jun 23, 2009
  • Filed:
    Dec 21, 2006
  • Appl. No.:
    11/614141
  • Inventors:
    George Kemble - Saratoga CA, US
    Gregory M. Duke - Redwood City CA, US
    Richard Spaete - Emerald Hills CA, US
  • Assignee:
    MedImmune, LLC - Gaitherburg MD
  • International Classification:
    A61K 39/12
    A61K 39/245
    C12Q 1/70
  • US Classification:
    4242041, 4242051, 4242301, 435 5
  • Abstract:
    A method is provided for attenuating a cytomegalovirus comprising functionally disrupting an open reading frame of a Toledo genome region or its homolog and making chimeric CMV virus genomes.

Get Report for Richard R Spaete from Emerald Hills, CA, age ~77
Control profile